Latest News
Shanghai lights up Times Square with Chinese New Year greeting
SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- A news report from
english.shanghai.gov.cn
Wanxiang A123 Ends the Era of Thermal Runaway with Semi-Solid-State and Immersion Cooling Technologies
With nearly 50 energy storage fires reported globally in the past year, thermal runaway has emerged as the industry's most critical safety challenge. DETROIT, Feb. 6, 2026 /PRNewswire/ -- Wanxiang A123 Systems Corp. unveiled a next-generation safety solution at its"Gathering Stars, Smart Storage ...
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
SEONGNAM, South Korea, Feb. 6, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO:Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the initiation of a Phase 1 clinical trial inthe United ...
Japonisme Reignites in Tokyo's Mukojima: A New Cultural Experience Invites Visitors to Walk, Print, and Take Home the World of Hokusai
– Experience Edo Culture with All Five Senses through an Ukiyo-e Walking Tour, Woodblock Printing Workshop, and Artisan Studio Shopping – TOKYO, Feb. 5, 2026 /PRNewswire/ -- A new cultural tourism program titled "Ukiyo-e Guided Walking Tour + Woodblock Printing Experience and Artisan Studio ...
Images over two decades: From Yixian to the world
BEIJING, Feb. 6, 2026 /PRNewswire/ -- This is a report from China.org.cn:   When a beam of light travels through Yixian county for 20 years, what does it illuminate? It lights up moments captured by Associated Press contract photographer Dan Sandoval in Xidi village: beneat...
TIER IV selected for ATLA-led study exploring autonomous driving applications for SDF facilities
TOKYO, Feb. 4, 2026 /PRNewswire/ -- TIER IV
Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer
HONG KONG, Feb. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the National Medic...
Sky Labs Signs Exclusive Distribution Agreement with Otsuka Pharmaceutical for 'CART BP pro' in Japan
- Secures distribution agreement to launch CART BP pro in the Japanese hospital and clinic market - Leveraging proven technology with adoptions in 1,700+ medical institutions and national health insurance coverage in Korea SEOUL, South Korea, Feb. 5, 2026 /PRNewswire/ -- Sky Labs Inc. (CEO Jack ...
VARON Marks Valentine's Day With Health-Focused Savings That Put Care First
Love looks like care. This Valentine's Day, VARON invites families to show love
in a way that helps loved ones breathe easier—at home and on the go.
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- VARON
Monport Positions Laser Engraving as a Growing Trend for Valentine's Day Personalized Gifts
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- As Valentine's Day approaches, Monport
Laser
Dreame Launches Aero Pro: The Next-Generation Wet Dry Vacuum with Ultra-Thin Design for Effortless, Deeper Cleaning
LOS ANGELES, Feb. 5, 2026 /PRNewswire/ -- Dreame, a global innovator in smart home, today announced the launch of the Aero Pro, a wet dry vacuum engineered to be the slim, strong, next-generation cleaner. It delivers a unique combination of power, access, and intelligence—with a groundbreaking ul...
COSRX's Viral Peptide Eye Patch Gets a Pink Makeover for Limited Valentine's Skincare Drop Now on Amazon
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- Just in time for Valentine's day,
science-driven K-beauty brand COSRX is launching a limited-edition Pink version
of its viral bestseller,The Peptide Collagen Hydrogel Eye Patch
LifeZoom Introduces the Oclux Red Light Eye Mask--A Naturally Restorative, Aesthetics-Driven Solution for the Effects of Screen-Based Life
NEW YORK, Feb. 5, 2026 /PRNewswire/ -- LifeZoom, a natural-restorative brand, today launches Oclux, a red light eye mask that expands the company's red light product lineup. Positioned as a holistic solution that balances visual aesthetics, user experience, and daily rhythms, Oclux is designed to...
2026 Spring Festival Gala Cultural Pop-up Stores Debut in Yiwu: When Artistry Meets Urban Vibrancy
YIWU, China, Feb. 5, 2026 /PRNewswire/ -- A news report from Yiwu Media Convergence Center:   On February 4th, the 2026 Spring Festival Gala Cultural Pop-up Store at the Yiwu Centre shopping district was bustling with crowds. Inside, a dazzling array of creative products fi...
e-STORAGE and Sunraycer Announce 503 MWh Battery Energy Storage Projects in Texas
KITCHENER, ON, Feb. 5, 2026 /PRNewswire/ -- Canadian Solar Inc.
Jin Medical CEO Fireside Chat
CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat onFebruary 2, 2026 where the CEO sha...
NITECORE Sets a New Standard for Ultralight Power: the New 143g, IPX7-Rated NB10000 Gen4
GUANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- The NITECORE
DLG Launches LuxuryIQ MCP: The Luxury Industry's First AI Data Integration Layer
GENEVA, Feb. 5, 2026 /PRNewswire/ -- DLG (Digital Luxury Group)
Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansion
GARLAND, Texas, Feb. 5, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and advanced electric mobility solutions, today announced its participation in the 2026 Golf Course Superintendents Association of America Conference and Trade Show, t...
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
* NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source. * Unlike ISM8969, Insilico's brain-penetrant NLR...
Week's Top Stories
Most Reposted
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 328 media titles]
2026-02-24 12:00HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 310 media titles]
2026-02-26 09:30Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 308 media titles]
2026-02-26 19:57Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 302 media titles]
2026-02-24 16:13SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 300 media titles]
2026-03-02 09:15